Latest Asx News

Venari Minerals has revised its Exploration Target for the Red Mountain Lithium Project in Nevada, revealing a potential lithium resource up to 18.6 million tonnes of Lithium Carbonate Equivalent. The company plans extensive drilling and sampling in 2026 to expand and upgrade this promising resource.

Chrysos Corporation Limited reported a robust 1H FY26 with revenue up 49% and EBITDA soaring 152%, driven by expanding adoption of its PhotonAssay technology and strategic global deployments.

Magellan Financial Group reported a 27% drop in statutory net profit but maintained stable operating profit and increased earnings per share by 5%, supported by ongoing share buybacks. The company declared a fully franked interim dividend up 50%, reflecting confidence despite investment performance challenges.

Dexus has announced a new on-market buyback of up to 10% of its securities, aiming to address the disconnect between its market valuation and underlying asset values while maintaining capital discipline.

INOVIQ Limited reported a $3.96 million net loss for H1 2026, driven by increased R&D spend, while securing $10.2 million to accelerate its exosome-based cancer diagnostics and therapeutics pipeline.

Tivan Limited has initiated comprehensive geophysical surveys across its Molyhil Tungsten and Sandover Fluorite Projects, aiming to refine exploration targets and guide drilling in 2026. The program includes advanced airborne and ground surveys designed to reveal new mineralisation beneath cover.

Strickland Metals reports robust gold intercepts from recent drilling at the Gradina Deposit within its Rogozna Project in Serbia, highlighting significant potential to expand the resource. The company is well-capitalised and gearing up for further exploration and resource updates.

Nelson Resources has identified high-grade gold and silver mineralisation in intrusion-hosted veins at its Gold Point Project in Nevada, with rock chip samples reaching up to 15.1g/t gold. The discovery expands the known mineralised footprint and sets the stage for maiden drilling in Q2 2026.

Starpharma reports a $1.37 million profit for H1 FY26, driven by a major upfront payment from Genentech and progress in its radiopharmaceutical pipeline. The biotech also expands its consumer health footprint amid growing partnerships.

SHAPE Australia Corporation Limited has reported a robust first half of FY26, with significant gains in revenue, profits, and project pipeline, underpinned by strategic sector diversification and a key acquisition.

Euro Manganese Inc. reported progress on its Chvaletice and Bécancour manganese projects, securing funding amendments and advancing permitting despite ongoing financial pressures. The company is positioned to benefit from growing demand for high-purity manganese in lithium-ion batteries amid evolving market dynamics.

Australian Finance Group Ltd (AFG) has reported a record-breaking half-year profit for HY26, driven by strong broker network growth and improved funding terms that reduce cash rate sensitivity.